We would like to run RNA seq- we have 8 samples. Do you have any experience with running the phix control WITH one of the samples? Could we still use the phi x as the control this way?
Announcement
Collapse
No announcement yet.
X
-
mRNA seq
We have been running RNA-seq with out a PhiX for over a year and it works fine. Giving up a lane for a standard is too expensive. The only reason you need a PhiX besides QC is if you are doing an unbalanced sample such as ChIP-seq, small RNA, Methyl-seq, or an unbalanced sequence. If you really want you can spike PhiX into your your sample at ~1% for QC but I do not believe this would help for phasing or matrix generation if your sample is unbalanced.
-
It's just that the GAII "calibrates" its matrix for the base calling step in the first cycles. In order to have a good calibration, the base abundancy in these cycles must be rather equal (25% A, 25% G, 25% C, 25% T, more or less).
Usually, you use PhiX as a reference balanced sample. But if you know that at least one of your samples is balanced, you can specify to the machine to use it as a reference.
Comment
-
As a core lab - we run a .04pM PhiX spike in each lane. Even if the clients library fails to produce clusters there is still enough to align PhiX & show that it was not an instrument problem. Bruce is correct it won't help with matrix/phasing etc if you have a biased sample you're trying to rescue.
The version of RTA/OLB you're using makes a huge difference, the newest RTA (1.6.47) handles RNA & CHiP much better than previous versions. If you do need to use OLB & a control lane to rescue samples - you don't have to use PhiX. Say you've got a good human genomic lane on that same flowcell -- you can use that as your control-lane. The only situation I've come across that you can't rescue is when the lane is just too over-concentrated - but a control lane wouldn't help in that situation either.
Comment
-
Yes -- you need an iCOM account, I believe you need your FAS to set it up for you.
Go here:
https://icom.illumina.com/
Once it's set up there will be a download section -- look under software.
You can download OLB v1.6.1 and run basecalling from images -- but it sounds like you're perhaps still on the 1.44mm flowcells, so if you're going to use Gerald for alignment you may have to use Casava v1.5.1
Comment
-
Originally posted by cbrennan View PostAs a core lab - we run a .04pM PhiX spike in each lane. Even if the clients library fails to produce clusters there is still enough to align PhiX & show that it was not an instrument problem. Bruce is correct it won't help with matrix/phasing etc if you have a biased sample you're trying to rescue.
Also we're multiplexing samples (running a control lane) but wanted to spike our samples with phix to help give the sample lanes more diversity. Does anyone have any experience with that? I'm wondering at what concentration to use. A little background, our barcodes were designed ourselves, we are not using Illumina's barcoding system.
Comment
-
PhiX Spiking
Originally posted by cmawhinney View PostWhen do you add your PhiX to the sample? I'm assuming if it's already at a pM concentration then it's after denaturation and you're adding PhiX diluted in HT1 to your samples that are denatured and diluted in HT1 as well.
Also we're multiplexing samples (running a control lane) but wanted to spike our samples with phix to help give the sample lanes more diversity. Does anyone have any experience with that? I'm wondering at what concentration to use. A little background, our barcodes were designed ourselves, we are not using Illumina's barcoding system.
I don't think that this will help you at all with base composition in barcoded samples. The software is looking for a somewhat uniform base distribution and 0.5% will not help if you only have two (or three) out of four bases present on any given cycle. We also use our own barcodes and PhiX at that concentration is basically invisible compared to the samples present.
Comment
-
I use the same sort of protocol as btarrier.
Denature sample and PhiX separately, add PhiX to sample. However, I use only 2uL of a 600pM PhiX (subtracting that 2uL from the HT1 volume added to the sample), giving 1% PhiX.
So far this has been working well.
We simply include a balanced sample in each run and set it as the control lane, thus avoiding sacrificing a lane to PhiX
We've never run a flowcell without an unbiased sample, as the addition of PhiX is not enough to normalize the base ratio and assure correcting calling.Last edited by KorNor; 08-06-2010, 05:54 AM.
Comment
-
Originally posted by btarrier View PostI don't think that this will help you at all with base composition in barcoded samples. The software is looking for a somewhat uniform base distribution and 0.5% will not help if you only have two (or three) out of four bases present on any given cycle. We also use our own barcodes and PhiX at that concentration is basically invisible compared to the samples present.
These samples were run with v2/3 reagents and thus run on version 1.5 of the Pipeline. I am now trying to run on OLB 1.6 as well as tweaking a lot of the parameters (for example setting it to use 10 bases, as opposed to the default of 4 in OLB 1.6) for cluster identification and it's not helping that much. FYI, We did run a separate control lane of PhiX as well.
If a anyone has any tricks for the analysis of barcoded samples! Since front indexing isn't an Illumina supported protocol they aren't much help.
Comment
-
cmawhinney -- did you try running OLB on a few tiles out past the barcode to generate a crosstalk matrix, and then run a full pipeline from cycle 1 importing that matrix? That's worked for me in the past.
Comment
Latest Articles
Collapse
-
by seqadmin
At the intersection of cytogenetics and genomics lies the exciting field of cytogenomics. It focuses on studying chromosomes at a molecular scale, involving techniques that analyze either the whole genome or particular DNA sequences to examine variations in structure and behavior at the chromosomal or subchromosomal level. By integrating cytogenetic techniques with genomic analysis, researchers can effectively investigate chromosomal abnormalities related to diseases, particularly...-
Channel: Articles
Yesterday, 06:26 AM -
-
by seqadmin
Cancer research has been transformed through numerous molecular techniques, with RNA sequencing (RNA-seq) playing a crucial role in understanding the complexity of the disease. Maša Ivin, Ph.D., Scientific Writer at Lexogen, and Yvonne Goepel Ph.D., Product Manager at Lexogen, remarked that “The high-throughput nature of RNA-seq allows for rapid profiling and deep exploration of the transcriptome.” They emphasized its indispensable role in cancer research, aiding in biomarker...-
Channel: Articles
09-07-2023, 11:15 PM -
-
by seqadmin
Ribonucleic acid (RNA) represents a range of diverse molecules that play a crucial role in many cellular processes. From serving as a protein template to regulating genes, the complex processes involving RNA make it a focal point of study for many scientists. This article will spotlight various methods scientists have developed to investigate different RNA subtypes and the broader transcriptome.
Whole Transcriptome RNA-seq
Whole transcriptome sequencing...-
Channel: Articles
08-31-2023, 11:07 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Today, 06:57 AM
|
0 responses
6 views
0 likes
|
Last Post
by seqadmin
Today, 06:57 AM
|
||
Started by seqadmin, Yesterday, 07:53 AM
|
0 responses
8 views
0 likes
|
Last Post
by seqadmin
Yesterday, 07:53 AM
|
||
Multiplexed Biomarker Detection with Nanopore Technology: A Leap in Precision Diagnostics
by seqadmin
Started by seqadmin, 09-25-2023, 07:42 AM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-25-2023, 07:42 AM
|
||
Started by seqadmin, 09-22-2023, 09:05 AM
|
0 responses
44 views
0 likes
|
Last Post
by seqadmin
09-22-2023, 09:05 AM
|
Comment